台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國光生

(4142)
可現股當沖
  • 股價
    22.35
  • 漲跌
    ▲0.15
  • 漲幅
    +0.68%
  • 成交量
    1,140
  • 產業
    上市 生技醫療類股
  • 635人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
國光生 (4142)籌碼相關-台灣匯立 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣匯立 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/21122.2500.0022.3516470.15%
2024/11/2000.0029821.9522.20-298641-46.46% 大賣/鉅額交易
2024/11/018524.4200.0024.658564413.19%
2024/10/1500.00725.5525.55-7867-0.81%
2024/09/193127.2500.0027.25311,0492.95%
2024/09/1618727.2700.0027.101871,07217.44% 大買/鉅額交易
2024/09/108727.3400.0027.40871,2257.10%
2023/09/2600.003234.5034.50-32901-3.55%
2023/06/2100.00137.3537.30-11,089-0.09%
2023/02/0900.001241.1541.15-122,065-0.58%
2022/12/1900.00836.0237.85-81,646-0.49%
2022/11/0300.0010334.4434.40-1032,056-5.01% 大賣/鉅額交易
2022/09/301934.3000.0034.30192,7610.69%
2022/07/191338.0000.0038.00133,2340.40%
2022/07/121939.4200.0039.25193,3780.56%
2022/06/1700.001338.5038.50-133,009-0.43%
2022/05/311435.3000.0035.30142,9320.48%
2022/04/2500.00741.6541.65-73,155-0.22%
2021/12/202944.7100.0044.60292,2201.31%
2021/11/0300.0040644.4344.50-4063,681-11.03% 大賣/鉅額交易
2021/11/0200.0054344.5244.50-5433,697-14.69% 大賣/鉅額交易
2021/11/0100.0032543.9643.95-3253,678-8.83% 大賣/鉅額交易
2021/10/2900.0028344.0443.95-2833,673-7.70% 大賣/鉅額交易
2021/10/2800.0049244.7744.60-4923,675-13.39% 大賣/鉅額交易
2021/10/2000.002744.3544.20-273,806-0.71%
2021/10/1400.002542.8943.50-254,349-0.57%
2021/09/0200.0012251.8551.00-1224,856-2.51% 大賣/鉅額交易
2021/07/135050.5000.0049.055014,1900.35%
2021/06/187853.3000.0053.307817,1990.45%
2021/03/295158.1000.0058.105114,2170.36%
2021/03/2300.001455.9055.90-1412,210-0.11%
2021/02/026547.9000.0048.95659,4180.69%
2021/01/2700.001550.6050.60-159,359-0.16%
2021/01/192450.1000.0050.102410,3170.23%
2021/01/072551.6000.0051.602510,3740.24%
2021/01/053153.7000.0053.703110,4690.30%
2020/11/301263.8300.0064.201214,0530.09%
2020/11/183261.7000.0061.603214,3830.22%
2020/10/303058.3000.0058.303018,8050.16%
2020/07/0922575.7700.0075.5022548,1000.47% 大買/鉅額交易
2020/06/1900.0027066.7066.70-27038,954-0.69% 大賣/鉅額交易
2020/06/1100.0031162.8456.60-31131,525-0.99% 大賣/鉅額交易
2020/05/1892045.6800.0047.6592030,5073.02% 大買/鉅額交易
國光生財報/前三季稅後淨損1.94億元 每股淨損0.46元UDN聯合新聞網-7天前
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
國光生 相關文章